Innovative Molecules Progresses to Phase 2 Trials for Oral Adibelivir After Successful Phase 1 Completion Innovative Molecules GmbH has successfully completed Phase 1 of their oral adibelivir program, moving forward to Phase 2 aimed at treating herpes infections effectively.

Innovative Molecules Progresses to Phase 2 Trials for Oral Adibelivir After Successful Phase 1 Completion #Germany #Munich #Adibelivir #Innovative_Molecules #HSV_Treatment